A Blood Test for 50 Cancers Goes Before the FDA: An Oncologist Explains What the Evidence Really Shows

The Galleri multi-cancer blood test found more cancers and cut stage 4 diagnoses in the largest trial of its kind, but it missed its main goal. A cancer specialist explains how to read the results and what they mean for patients considering the test.